380 related articles for article (PubMed ID: 11167798)
1. Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma.
Sawyer JR; Lukacs JL; Thomas EL; Swanson CM; Goosen LS; Sammartino G; Gilliland JC; Munshi NC; Tricot G; Shaughnessy JD; Barlogie B
Br J Haematol; 2001 Jan; 112(1):167-74. PubMed ID: 11167798
[TBL] [Abstract][Full Text] [Related]
2. Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping.
Sawyer JR; Lukacs JL; Munshi N; Desikan KR; Singhal S; Mehta J; Siegel D; Shaughnessy J; Barlogie B
Blood; 1998 Dec; 92(11):4269-78. PubMed ID: 9834233
[TBL] [Abstract][Full Text] [Related]
3. Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma.
Rao PH; Cigudosa JC; Ning Y; Calasanz MJ; Iida S; Tagawa S; Michaeli J; Klein B; Dalla-Favera R; Jhanwar SC; Ried T; Chaganti RS
Blood; 1998 Sep; 92(5):1743-8. PubMed ID: 9716604
[TBL] [Abstract][Full Text] [Related]
4. Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin.
Sawyer JR; Tricot G; Mattox S; Jagannath S; Barlogie B
Blood; 1998 Mar; 91(5):1732-41. PubMed ID: 9473240
[TBL] [Abstract][Full Text] [Related]
5. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
Nishida K; Tamura A; Nakazawa N; Ueda Y; Abe T; Matsuda F; Kashima K; Taniwaki M
Blood; 1997 Jul; 90(2):526-34. PubMed ID: 9226151
[TBL] [Abstract][Full Text] [Related]
6. Der(16)t(1;16)(q10;p10) in multiple myeloma: a new non-random abnormality that is frequently associated with Burkitt's-type translocations.
Mugneret F; Sidaner I; Favre B; Manone L; Maynadié M; Caillot D; Solary E
Leukemia; 1995 Feb; 9(2):277-81. PubMed ID: 7869764
[TBL] [Abstract][Full Text] [Related]
7. Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia.
Taniwaki M; Nishida K; Takashima T; Nakagawa H; Fujii H; Tamaki T; Shimazaki C; Horiike S; Misawa S; Abe T
Blood; 1994 Oct; 84(7):2283-90. PubMed ID: 7919347
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression.
Nanjangud G; Rao PH; Teruya-Feldstein J; Donnelly G; Qin J; Mehra S; Jhanwar SC; Zelenetz AD; Chaganti RS
Cytogenet Genome Res; 2007; 118(2-4):337-44. PubMed ID: 18000388
[TBL] [Abstract][Full Text] [Related]
9. Spectral karyotyping identifies new rearrangements, translocations, and clinical associations in diffuse large B-cell lymphoma.
Nanjangud G; Rao PH; Hegde A; Teruya-Feldstein J; Donnelly G; Qin J; Jhanwar SC; Zelenetz AD; Chaganti RS
Blood; 2002 Apr; 99(7):2554-61. PubMed ID: 11895793
[TBL] [Abstract][Full Text] [Related]
10. Four new recurring translocations in non-Hodgkin lymphoma.
Levine EG; Arthur DC; Machnicki J; Frizzera G; Hurd D; Peterson B; Gajl-Peczalska KJ; Bloomfield CD
Blood; 1989 Oct; 74(5):1796-800. PubMed ID: 2506953
[TBL] [Abstract][Full Text] [Related]
11. Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality.
Nagoshi H; Taki T; Hanamura I; Nitta M; Otsuki T; Nishida K; Okuda K; Sakamoto N; Kobayashi S; Yamamoto-Sugitani M; Tsutsumi Y; Kobayashi T; Matsumoto Y; Horiike S; Kuroda J; Taniwaki M
Cancer Res; 2012 Oct; 72(19):4954-62. PubMed ID: 22869583
[TBL] [Abstract][Full Text] [Related]
12. Multicolor spectral karyotyping of serous ovarian adenocarcinoma.
Rao PH; Harris CP; Yan Lu X; Li XN; Mok SC; Lau CC
Genes Chromosomes Cancer; 2002 Feb; 33(2):123-32. PubMed ID: 11793438
[TBL] [Abstract][Full Text] [Related]
13. Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.
Chiecchio L; Dagrada GP; Ibrahim AH; Dachs Cabanas E; Protheroe RK; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
Haematologica; 2009 Dec; 94(12):1708-13. PubMed ID: 19996118
[TBL] [Abstract][Full Text] [Related]
14. Recurrent chromosomal rearrangements involving breakpoints 3p21 and 19q13 in Chinese IgD multiple myeloma detected by G-banding and multicolor spectral karyotyping: a review of IgD karyotype literature.
Ng MH; Wong N; Tsang KS; Cheng SH; Chung YF; Lo KW
Hum Pathol; 2001 Sep; 32(9):1016-20. PubMed ID: 11567234
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetics in multiple myeloma: a multicenter study of 24 patients with t(11;14)(q13;q32) or its variant.
Laï JL; Michaux L; Dastugue N; Vasseur F; Daudignon A; Facon T; Bauters F; Zandecki M
Cancer Genet Cytogenet; 1998 Jul; 104(2):133-8. PubMed ID: 9666807
[TBL] [Abstract][Full Text] [Related]
16. Different breakage-prone regions on chromosome 1 detected in t(11;14)-positive mantle cell lymphoma cell lines and multiple myeloma cell lines are associated with different tumor progression-related mechanisms.
Rudolph C; Liehr T; Steinemann D; Emura M; Daibata M; Matsuo Y; Emi N; Abe M; Lai R; Mrasek K; Claussen U; Schlegelberger B
Cytogenet Genome Res; 2006; 112(3-4):213-21. PubMed ID: 16484775
[TBL] [Abstract][Full Text] [Related]
17. Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma.
Trakhtenbrot L; Hardan I; Koren-Michowitz M; Oren S; Yshoev G; Rechavi G; Nagler A; Amariglio N
Genes Chromosomes Cancer; 2010 Jan; 49(1):17-27. PubMed ID: 19787791
[TBL] [Abstract][Full Text] [Related]
18. A variant Burkitt-type translocation (8;22)(q24;q11) in multiple myeloma. Report of a new case and review of the literature.
Yamamoto K; Hamaguchi H; Nagata K; Taniwaki M
Cancer Genet Cytogenet; 1998 Jul; 104(2):98-103. PubMed ID: 9666801
[TBL] [Abstract][Full Text] [Related]
19. Identification of recurrent chromosomal breakpoints in multiple myeloma with complex karyotypes by combined G-banding, spectral karyotyping, and fluorescence in situ hybridization analyses.
Sáez B; Martín-Subero JI; Largo C; Martín MC; Odero MD; Prosper F; Siebert R; Calasanz MJ; Cigudosa JC
Cancer Genet Cytogenet; 2006 Sep; 169(2):143-9. PubMed ID: 16938572
[TBL] [Abstract][Full Text] [Related]
20. Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2.
Hilgenfeld E; Padilla-Nash H; McNeil N; Knutsen T; Montagna C; Tchinda J; Horst J; Ludwig WD; Serve H; Büchner T; Berdel WE; Schröck E; Ried T
Br J Haematol; 2001 May; 113(2):305-17. PubMed ID: 11380393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
